Selected References:
- An Y, et al. 2014. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf), 80(3):425-431.
- Chan E. 1993. Displacement of bilirubin from albumin by berberine. Biol Neonate, 63:201-208.
- Di Pierro F, et al. 2023. Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial. Frontiers in pharmacology, 14:1269605.
- Ha S & Song X. 2024. Berberine as adjuvant therapy for treating reduced fertility potential in women with polycystic ovary syndrome: A meta-analysis of randomized controlled trials. Explore (New York, N.Y.), 20(6):103040
- Imanshahidi M, et al. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res, 22:999–1012.
- Lampe KF. 1999. Berberine. In DeSmet PAGM, Keller K, Hnsel R, Chandler RF. Adverse effects of herbal drugs, vol 1: 97-103. Springer-Verlag, Berlin.
- Zhao S, et al. 2021. Effect and mechanism of berberine against polycystic ovary syndrome. Biomedicine & Pharmacotherapy, 138:111468.
